<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04980911</url>
  </required_header>
  <id_info>
    <org_study_id>2021-02Obs-CHRMT</org_study_id>
    <nct_id>NCT04980911</nct_id>
  </id_info>
  <brief_title>Iron Deficiency and Anemia in Cardiac Surgery</brief_title>
  <acronym>DFACCVM</acronym>
  <official_title>Iron Deficiency and Anemia in Cardiovascular Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Régional Metz-Thionville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Régional Metz-Thionville</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anemia and preoperative iron deficit in cardiac surgery are associated by an increased volume&#xD;
      of transfusion and an increase in complications and/or mortality. Recent studies have shown&#xD;
      that EPO and iron administration the days preceding the operation results in a reduction of&#xD;
      perioperative transfusion for patients with preoperative anemia.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 12, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of transfusion</measure>
    <time_frame>Day 7</time_frame>
    <description>number of perioperative and post-operative transfusion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of post operative complications</measure>
    <time_frame>Day 7</time_frame>
    <description>Number of post-operative complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of death</measure>
    <time_frame>Day 7</time_frame>
    <description>Percentage of post-operative death</description>
  </secondary_outcome>
  <enrollment type="Anticipated">320</enrollment>
  <condition>Anemia</condition>
  <condition>Cardiac Surgery</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with iron deficiency and with a scheduled cardiac surgery&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient with cardiac surgery&#xD;
&#xD;
          -  With iron deficiency with or without anemia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Anemia without iron deficiency&#xD;
&#xD;
          -  Iron overload&#xD;
&#xD;
          -  Jehovah's witnesses&#xD;
&#xD;
          -  Endocarditis&#xD;
&#xD;
          -  Treating neoplasia&#xD;
&#xD;
          -  Uncontrolled hypertension&#xD;
&#xD;
          -  With infection&#xD;
&#xD;
          -  Alfa-epoetin hypersensitivity&#xD;
&#xD;
          -  Hypersensitivity of hamster's protein&#xD;
&#xD;
          -  Erythroblastopenia induced by erythropoietin&#xD;
&#xD;
          -  Ferinject or mannitol allergy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Stephane Mouren, MD</last_name>
    <phone>387553069</phone>
    <phone_ext>0033</phone_ext>
    <email>s.mouren@chr-metz-thionville.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mohammad Rahmati, MD</last_name>
    <email>m.rahmati@chr-metz-thionville.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHR Metz Thionville</name>
      <address>
        <city>Metz</city>
        <state>Moselle</state>
        <zip>57085</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadia Ouamara</last_name>
      <phone>387557752</phone>
      <phone_ext>0033</phone_ext>
      <email>n.ouamara@chr-metz-thionville.fr</email>
    </contact>
    <contact_backup>
      <last_name>Sandra Marchionni</last_name>
      <phone>387557750</phone>
      <phone_ext>0033</phone_ext>
      <email>s.marchionni@chr-metz-thionville.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>July 21, 2021</study_first_submitted>
  <study_first_submitted_qc>July 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 28, 2021</study_first_posted>
  <last_update_submitted>July 21, 2021</last_update_submitted>
  <last_update_submitted_qc>July 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

